[1]
Cyprian, F.S., Akhtar, S., Gatalica, Z. and Vranic, S. 2019. Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer. BJBMS. 19, 3 (Aug. 2019), 227-233. DOI:https://doi.org/10.17305/bjbms.2019.4204.